MASSTECH, INC.

Medtech

Mass spectrometry imaging platform combining UV laser and matrix-assisted laser desorption ionisation (MALDI) for peptide, lipid, and metabolite detection in tissue samples

apmaldi.com →
Grants
$589K
4 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Lossless interface for ultrasensitive MS-based proteomics of single cells$144,313
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · New Ionization Technique for MS Imaging$150,000
Federal grantDepartment of Health and Human Services · Phase I · Development of new approaches to FTICR mass spectrometry$150,000
Federal grantDepartment of Health and Human Services · Phase I · New Subatmospheric MALDI-MS Imaging Platform$144,313
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1555Lightfield Medical, Inc.—$3.1M
1556PhysioLogic Devices, Inc.—$3.0M
1557Skin Laundry Holdings, Inc.—$3.0M
1558MASSTECH, INC.——
1559Pulsario Enterprise Holdings, Inc—$20M
1560Paerosol LLC—$250K
1561BioMEMS Diagnostics, Inc.—$3.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.